Omenn syndrome
Template:DiseaseDisorder infobox
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
WikiDoc Resources for Omenn syndrome |
Articles |
---|
Most recent articles on Omenn syndrome Most cited articles on Omenn syndrome |
Media |
Powerpoint slides on Omenn syndrome |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Omenn syndrome at Clinical Trials.gov Trial results on Omenn syndrome Clinical Trials on Omenn syndrome at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Omenn syndrome NICE Guidance on Omenn syndrome
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Omenn syndrome Discussion groups on Omenn syndrome Patient Handouts on Omenn syndrome Directions to Hospitals Treating Omenn syndrome Risk calculators and risk factors for Omenn syndrome
|
Healthcare Provider Resources |
Causes & Risk Factors for Omenn syndrome |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Omenn syndrome is an autosomal recessive severe combined immunodeficiency[1] associated with mutations in the recombination activating genes (RAG1 and RAG2), affecting circulating levels of both B-cells and T-cells.
Symptoms
The symptoms are very similar to graft-versus-host disease (GVHD). This is because the patients have some T cells with limited levels of recombination with the poor RAG genes. These T cells are abnormal and have a very specific affinity for self antigens found in the thymus and in the periphery. Therefore, these T cells are auto-reactive and cause the GVHD phenotype.
Symptoms include:
- Desquamation (shedding the outer layers of skin)
- Chronic diarrhea
- Erythroderma (widespread reddening of the skin)
- Hepatosplenomegaly (simultaneous enlargement of both the liver and the spleen)
- Leukocytosis (elevation of the white blood cell count)
- Lymphadenopathy (swelling of one or more lymph nodes)
- Persistent bacterial infections
- Elevated serum IgE
Genetics
Treatment
Omenn syndrome is sometimes treated with bone marrow transplantation and cord blood stem cells.
External links
References
- ↑ Santagata S, Villa A, Sobacchi C, Cortes P, Vezzoni P (2000). "The genetic and biochemical basis of Omenn syndrome". Immunol Rev. 178: 64–74. doi:10.1034/j.1600-065X.2000.17818.x. PMID 11213808.